243 related articles for article (PubMed ID: 25034147)
1. Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression.
Ojha J; Secreto C; Rabe K; Ayres-Silva J; Tschumper R; Dyke DV; Slager S; Fonseca R; Shanafelt T; Kay N; Braggio E
Leukemia; 2014 Dec; 28(12):2395-8. PubMed ID: 25034147
[No Abstract] [Full Text] [Related]
2. BIRC-3 mutated monoclonal B lymphocytosis without evolution to chronic lymphocytic leukemia (CLL).
Nasr AA; Fund X; Barreau S; Desterke C; Borie C; Oudrhiri N; Faivre J; Bennaceur-Griscelli A; Turhan AG
Leuk Lymphoma; 2024 May; 65(5):692-695. PubMed ID: 38293748
[No Abstract] [Full Text] [Related]
3. Accumulation of DNA damage and alteration of the DNA damage response in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
Popp HD; Flach J; Brendel S; Ruppenthal S; Kleiner H; Seifarth W; Schneider S; Schulze TJ; Weiss C; Wenz F; Hofmann WK; Fabarius A
Leuk Lymphoma; 2019 Mar; 60(3):795-804. PubMed ID: 30376743
[TBL] [Abstract][Full Text] [Related]
4. What does it mean I have a monoclonal B-cell lymphocytosis?: Recent insights and new challenges.
Scarfò L; Ghia P
Semin Oncol; 2016 Apr; 43(2):201-8. PubMed ID: 27040697
[TBL] [Abstract][Full Text] [Related]
5. Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations.
Agathangelidis A; Ljungström V; Scarfò L; Fazi C; Gounari M; Pandzic T; Sutton LA; Stamatopoulos K; Tonon G; Rosenquist R; Ghia P
Haematologica; 2018 May; 103(5):865-873. PubMed ID: 29449433
[TBL] [Abstract][Full Text] [Related]
6. Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.
Morabito F; Mosca L; Cutrona G; Agnelli L; Tuana G; Ferracin M; Zagatti B; Lionetti M; Fabris S; Maura F; Matis S; Gentile M; Vigna E; Colombo M; Massucco C; Recchia AG; Bossio S; De Stefano L; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Tassone P; Negrini M; Monti S; Rossi D; Gaidano G; Ferrarini M; Neri A
Clin Cancer Res; 2013 Nov; 19(21):5890-900. PubMed ID: 24036852
[TBL] [Abstract][Full Text] [Related]
7. Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.
Molica S; Giannarelli D; Levato L; Gentile M; Mirabelli R; Morabito F
Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e55-60. PubMed ID: 25445470
[TBL] [Abstract][Full Text] [Related]
8. Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome.
Barrio S; Shanafelt TD; Ojha J; Chaffee KG; Secreto C; Kortüm KM; Pathangey S; Van-Dyke DL; Slager SL; Fonseca R; Kay NE; Braggio E
Leukemia; 2017 Jan; 31(1):170-176. PubMed ID: 27469216
[TBL] [Abstract][Full Text] [Related]
9. Low frequency mutations independently predict poor treatment-free survival in early stage chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.
Winkelmann N; Rose-Zerilli M; Forster J; Parry M; Parker A; Gardiner A; Davies Z; Steele AJ; Parker H; Cross NC; Oscier DG; Strefford JC
Haematologica; 2015 Jun; 100(6):e237-9. PubMed ID: 25710457
[No Abstract] [Full Text] [Related]
10. Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL).
Rawstron AC; Shanafelt T; Lanasa MC; Landgren O; Hanson C; Orfao A; Hillmen P; Ghia P
Cytometry B Clin Cytom; 2010; 78 Suppl 1(Suppl 1):S19-23. PubMed ID: 20839333
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal B-cell lymphocytosis: a reappraisal of its clinical implications.
Molica S; Mauro FR; Molica M; Del Giudice I; Foà R
Leuk Lymphoma; 2012 Sep; 53(9):1660-5. PubMed ID: 22335530
[TBL] [Abstract][Full Text] [Related]
12. Combined patterns of IGHV repertoire and cytogenetic/molecular alterations in monoclonal B lymphocytosis versus chronic lymphocytic leukemia.
Henriques A; Rodríguez-Caballero A; Nieto WG; Langerak AW; Criado I; Lécrevisse Q; González M; Pais ML; Paiva A; Almeida J; Orfao A
PLoS One; 2013; 8(7):e67751. PubMed ID: 23844084
[TBL] [Abstract][Full Text] [Related]
13. Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis.
Kleinstern G; Boddicker NJ; O'Brien DR; Allmer C; Rabe KG; Norman AD; Griffin R; Yan H; Ma T; Call TG; Bruins L; Brown S; Bonolo de Campos C; Hanson CA; Leis JF; Ding W; Vachon CM; Kay NE; Oakes CC; Parker AS; Brander DM; Weinberg JB; Furman RR; Shanafelt TD; Cerhan JR; Parikh SA; Braggio E; Slager SL
Blood Adv; 2024 May; 8(9):2118-2129. PubMed ID: 38359367
[TBL] [Abstract][Full Text] [Related]
14. Chronic lymphocytic leukaemia (CLL) and CLL-type monoclonal B-cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing.
Rawstron AC; Shingles J; de Tute R; Bennett F; Jack AS; Hillmen P
Cytometry B Clin Cytom; 2010; 78 Suppl 1():S42-6. PubMed ID: 20839337
[TBL] [Abstract][Full Text] [Related]
15. Molecular and cytogenetic characterization of expanded B-cell clones from multiclonal versus monoclonal B-cell chronic lymphoproliferative disorders.
Henriques A; Rodríguez-Caballero A; Criado I; Langerak AW; Nieto WG; Lécrevisse Q; González M; Cortesão E; Paiva A; Almeida J; Orfao A
Haematologica; 2014 May; 99(5):897-907. PubMed ID: 24488564
[TBL] [Abstract][Full Text] [Related]
16. The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring.
Dagklis A; Fazi C; Sala C; Cantarelli V; Scielzo C; Massacane R; Toniolo D; Caligaris-Cappio F; Stamatopoulos K; Ghia P
Blood; 2009 Jul; 114(1):26-32. PubMed ID: 19029437
[TBL] [Abstract][Full Text] [Related]
17. Non-CLL-like monoclonal B-cell lymphocytosis in the general population: prevalence and phenotypic/genetic characteristics.
Nieto WG; Teodosio C; López A; Rodríguez-Caballero A; Romero A; Bárcena P; Gutierrez ML; Langerak AW; Fernandez-Navarro P; Orfao A; Almeida J;
Cytometry B Clin Cytom; 2010; 78 Suppl 1():S24-34. PubMed ID: 20839335
[TBL] [Abstract][Full Text] [Related]
18. General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL.
Fazi C; Scarfò L; Pecciarini L; Cottini F; Dagklis A; Janus A; Talarico A; Scielzo C; Sala C; Toniolo D; Caligaris-Cappio F; Ghia P
Blood; 2011 Dec; 118(25):6618-25. PubMed ID: 21876118
[TBL] [Abstract][Full Text] [Related]
19. A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes.
McCarthy BA; Yancopoulos S; Tipping M; Yan XJ; Wang XP; Bennett F; Li W; Lesser M; Paul S; Boyle E; Moreno C; Catera R; Messmer BT; Cutrona G; Ferrarini M; Kolitz JE; Allen SL; Rai KR; Rawstron AC; Chiorazzi N
Immunol Res; 2015 Dec; 63(1-3):90-100. PubMed ID: 26318878
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis.
Parikh SA; Chaffee KG; Larson MC; Hampel PJ; Call TG; Ding W; Kenderian SS; Leis JF; Chanan-Khan AA; Conte MJ; Bowen D; Schwager SM; Slager SL; Hanson CA; Kay NE; Shanafelt TD
Haematologica; 2018 Jun; 103(6):e237-e240. PubMed ID: 29419435
[No Abstract] [Full Text] [Related]
[Next] [New Search]
